Solventum Corporation (SOLV) Revenue History
Annual and quarterly revenue from 2021 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2024)
SOLV's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
SOLV Revenue Analysis (2021–2025)
As of March 2, 2026, Solventum Corporation (SOLV) generated trailing twelve-month (TTM) revenue of $8.32 billion, reflecting slight decline in growth of -3.7% year-over-year. The most recent quarter (Q4 2025) recorded $2.00 billion in revenue, down 4.7% sequentially.
Looking at the longer-term picture, SOLV's historical revenue data shows a 3-year CAGR of +0.8%. The company achieved its highest annual revenue of $8.32 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows SOLV's business is primarily driven by Product (100%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HCSG (+6.3% YoY), AMN (-8.5% YoY), and CCRN (-22.1% YoY), SOLV has underperformed the peer group in terms of revenue growth. Compare SOLV vs HCSG →
Peer Comparison
Compare SOLV's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SOLVCurrent | $8.3B | -3.7% | - | 26.2% | |
| HCSG | $1.8B | +6.3% | +0.9% | 2.6% | |
| AMN | $3.0B | -8.5% | +6.1% | -3.4% | |
| CCRN | $1.3B | -22.1% | +10.3% | -1.3% | |
| CCEL | $32M | -0.3% | +0.1% | 10.9% | |
| AMS | $28M | +17.8% | +6.6% | -9.9% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $8.32B | +0.9% | $4.45B | 53.5% | $2.18B | 26.2% |
| 2024 | $8.25B | +0.7% | $4.59B | 55.6% | $1.04B | 12.6% |
| 2023 | $8.20B | +0.8% | $4.69B | 57.3% | $1.69B | 20.6% |
| 2022 | $8.13B | -0.5% | $4.70B | 57.7% | $1.69B | 20.8% |
| 2021 | $8.17B | - | $4.92B | 60.2% | $1.88B | 23.0% |
See SOLV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SOLV Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare SOLV vs AGIO
See how SOLV stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is SOLV's revenue growth accelerating or slowing?
SOLV revenue growth slowed to -3.7%, below the 5-year CAGR of N/A. TTM revenue is $8.3B. The deceleration marks a shift from historical growth rates.
What is SOLV's long-term revenue growth rate?
Solventum Corporation's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -3.7% is near this long-term average.
How is SOLV's revenue distributed by segment?
SOLV reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2021-2025 are available for download. Segment mix reveals concentration and diversification trends.